Teaching Lectures
08.00 - 08.40 |
Evidence based medicine: re-irradiation
C.Nieder (NO) |
New irradiation techniques for breast cancer
A.Fourquet (FR) |
MAESTRO Symposium
R.Hugon (FR)
A.Guimond (FR)
F.Husson (FR)
O.Haas (UK) |
MR imaging technology for RT
J.Kurhanewicz (USA) |
The evolution of Linac technology for stereotactic radiosurgery
T.Solberg (USA) |
Molecular diagnosis and prediction: genome wide methods and potential
C.West (UK)
|
Evidence based medicine: CNS tumours
R.Mirimanoff (CH) |
|
Symposia
08.45 - 10.00 |
Is there still a role for radiotherapy in paediatric oncology
A.Aitken (UK)
F.Saran (UK)
T.Björk Eriksson (SE) |
Tailoring for breast cancer radiotherapy
E.Senkus-Konefka (PL)
J.Yarnold (UK)
L.Boersma (NL) |
ESMO/ESSO/ESTRO
State of the art in the management of rectal cancer I
N.Scott (UK)
G.Brown (UK)
T.Wiggers (NL) |
4D RT & respiratory gating
H.McNair (UK)
J.Wolthaus (NL)
A.N.Pedersen (DK)
K.Brock (CA) |
Stereotactic body radiotherapy
I.Lax (SE)
W.Tome (USA)
R.Ruggeri (IT)
J.Nuyttens (NL) |
Tumour micro environment and radiation response
K.Rouschop (NL)
O.Feron (BE)
J.Erler (UK) |
Management of gynaecological tumours
K.Bergmark (SE)
E.Armstrong (UK)
L.Punt (UK) |
|
| 10.00 - 10.30 |
Coffee |
Symposia
10.30 - 11.45 |
Advances in the management of malignant glioma
A.Grosu (DE)
D.Weber (CH)
A.Dicker (USA) |
IMRT for breast cancer: a new standard?
C.Hurkmans (NL)
M.Mast (NL)
T.Nottrop (DK) |
ESMO/ESSO/ESTRO
State of the art in the management of rectal cancer II
I.Taylor (UK)
B.Glimelius (SE)
H.Schmoll (DE) |
Respiratory surrogates and tumour motion
JJ.Sonke (NL)
R.Prabhakar (IND)
G.Christensen (USA)
B.Paliwal (USA) |
Biological modelling in radiation oncology
R.Valdagni (IT)
J.Deasy (USA)
M.Ebert (AUS) |
Molecular imaging: from structures to treatment planning
M.Piert (USA)
J.Lee (BE)
M.MacManus (AUS) |
Late effects of radiation treatment -
Psychosocial care
L.Incrocci (NL)
M.Mascarin (IT)
A.Holst (SE) |
|
Award Lecture
11.50 - 12.30 |
Regaud lecture: K K Ang |
| 12.30 - 14.15 |
Lunch & poster viewing |
Dr Sennewald Medizintechnik - Satellite Symposium "Targeted Hyperthermia: a Powerful Trigger in Oncology" |
Merck - Satellite Symposium " ERBITUX - Setting new Standards in Head and Neck Cancer" |
|
|
|
|
Proffered Papers
14.15 - 15.15 |
Report on Phase III randomised trials |
Molecular biology in head & neck |
Debate: How much QA should be done for new technologies?
Speaker: G.Ibbott (USA) vs B.Mijnheer (NL)
Panel: C.Hurkmans (NL), E.Aird (UK), P.Nilsson (SE), N.Jornet (ES) |
Prediction and genomics |
Professional development |
GENEPI
E.van Veen (NL)
D.De Ruysscher (NL)
M.Tomsej (BE)
|
Proffered Papers
15.20 - 16.20 |
Prostate cancer |
Head & Neck II |
Target delineation |
Motion and uncertainties |
Clinical dose measurements |
Hypoxia and vasculature |
The RTT Core curriculum in Europe |
GENEPI-low RT
J.Polanska (PL)
M.Giphart-Gassler (NL)
P.O'Neill (UK) |
| 16.20 - 16.45 |
Coffee |
Award Lectures
16.45 - 17.45 |
Varian/Fowler/Accuray Awards |
Award Lecture
17.45 - 18.30 |
Van der Schueren Award: A Begg (NL) |